Nicolas Leveziel

7.4k total citations · 1 hit paper
88 papers, 1.7k citations indexed

About

Nicolas Leveziel is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Nicolas Leveziel has authored 88 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Ophthalmology, 44 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Epidemiology. Recurrent topics in Nicolas Leveziel's work include Retinal Diseases and Treatments (68 papers), Glaucoma and retinal disorders (31 papers) and Retinal Imaging and Analysis (30 papers). Nicolas Leveziel is often cited by papers focused on Retinal Diseases and Treatments (68 papers), Glaucoma and retinal disorders (31 papers) and Retinal Imaging and Analysis (30 papers). Nicolas Leveziel collaborates with scholars based in France, United Kingdom and United States. Nicolas Leveziel's co-authors include Eric H. Souied, Giuseppe Querques, G. Soubrane, G. Coscas, Rupert Bourne, Mark A. Bullimore, Pascale Benlian, Jennyfer Zerbib, Sylvie Bastuji‐Garin and D.I. Flitcroft and has published in prestigious journals such as Scientific Reports, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Nicolas Leveziel

81 papers receiving 1.7k citations

Hit Papers

The Risks and Benefits of... 2021 2026 2022 2024 2021 50 100 150

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nicolas Leveziel 1.4k 1.1k 466 324 86 88 1.7k
Jane D. Kivlin 430 0.3× 454 0.4× 222 0.5× 293 0.9× 22 0.3× 49 1.2k
Troels Vinding 1.2k 0.9× 815 0.8× 381 0.8× 227 0.7× 20 0.2× 30 1.5k
Ebru Toker 585 0.4× 644 0.6× 243 0.5× 56 0.2× 25 0.3× 63 1.2k
Melinda Y. Chang 645 0.5× 334 0.3× 167 0.4× 93 0.3× 15 0.2× 79 1.0k
Imran H. Yusuf 479 0.4× 151 0.1× 64 0.1× 273 0.8× 44 0.5× 63 903
Rainer Guthoff 735 0.5× 508 0.5× 91 0.2× 106 0.3× 14 0.2× 77 1.1k
Samantha R. De Silva 763 0.6× 482 0.5× 423 0.9× 445 1.4× 14 0.2× 50 1.2k
Shulamit Schwartz 752 0.6× 744 0.7× 197 0.4× 134 0.4× 6 0.1× 43 1.1k
Salvatore Cillino 1.1k 0.8× 774 0.7× 287 0.6× 126 0.4× 14 0.2× 65 1.4k
Eedy Mezer 370 0.3× 275 0.3× 293 0.6× 96 0.3× 7 0.1× 58 679

Countries citing papers authored by Nicolas Leveziel

Since Specialization
Citations

This map shows the geographic impact of Nicolas Leveziel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Leveziel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Leveziel more than expected).

Fields of papers citing papers by Nicolas Leveziel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Leveziel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Leveziel. The network helps show where Nicolas Leveziel may publish in the future.

Co-authorship network of co-authors of Nicolas Leveziel

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Leveziel. A scholar is included among the top collaborators of Nicolas Leveziel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Leveziel. Nicolas Leveziel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ling, Nina Tahhan, Kathryn J. Saunders, et al.. (2025). Factors Affecting the Lifetime Cost of Myopia and the Impact of Active Myopia Treatments in Europe. American Journal of Ophthalmology. 278. 212–221.
2.
Bullimore, Mark A., Serge Resnikoff, Alain M. Bron, et al.. (2025). The real-world effectiveness of defocus incorporated multiple segments and highly aspherical lenslets on myopia control: a longitudinal study from the French myopia cohort. BMJ Open Ophthalmology. 10(1). e002142–e002142.
4.
Bullimore, Mark A., Samantha Sze‐Yee Lee, Katrina L. Schmid, et al.. (2023). IMI—Onset and Progression of Myopia in Young Adults. Investigative Ophthalmology & Visual Science. 64(6). 2–2. 61 indexed citations
5.
Leveziel, Nicolas, Tasanee Braithwaite, Tünde Pető, et al.. (2023). Self-reported dual sensory impairment and related factors: a European population-based cross-sectional survey. British Journal of Ophthalmology. 108(3). 484–492. 7 indexed citations
6.
Bullimore, Mark A., et al.. (2021). Progression of myopia in teenagers and adults: a nationwide longitudinal study of a prevalent cohort. British Journal of Ophthalmology. 107(5). 644–649. 24 indexed citations
7.
Leveziel, Nicolas, Tasanee Braithwaite, Tünde Pető, et al.. (2020). Self‐reported visual difficulties in Europe and related factors: a European population‐based cross‐sectional survey. Acta Ophthalmologica. 99(5). 559–568. 8 indexed citations
8.
Monville, Christelle, et al.. (2019). iPSC-RPE cells derived from atrophic age-related macular degeneration patients have a typical disease phenotype. Investigative Ophthalmology & Visual Science. 60(9). 1224–1224. 1 indexed citations
9.
Monville, Christelle, et al.. (2018). hRPE cells derived from induced pluripotent stem cells are more sensitive to oxidative stress than ARPE-19 cells. Experimental Eye Research. 177. 76–86. 7 indexed citations
10.
Holz, Frank G., Adnan Tufail, Nicolas Leveziel, et al.. (2016). Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE. Ophthalmologica. 236(1). 19–28. 21 indexed citations
11.
Zerbib, Jennyfer, Johanna M. Seddon, Florence Richard, et al.. (2015). rs5888 Variant of <em>SCARB1</em> Gene Is a Possible Susceptibility Factor for Age-Related Macular Degeneration. Figshare. 16 indexed citations
12.
Leveziel, Nicolas, Stéphanie Ragot, Elise Gand, et al.. (2015). Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients. Medicine. 94(33). e1220–e1220. 8 indexed citations
13.
Maurel, Frédérique, et al.. (2015). Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study. Ophthalmologica. 234(3). 151–159. 29 indexed citations
14.
Leveziel, Nicolas, Adnan Tufail, Hyeong Gon Yu, et al.. (2014). Ranibizumab treatment outcome in visual impairment due to myopic choroidal neovascularization: RADIANCE subgroup analysis based on baseline ocular characteristics. Investigative Ophthalmology & Visual Science. 55(13). 4956–4956. 1 indexed citations
16.
Forte, Raimondo, Giuseppe Querques, Lea Querques, et al.. (2013). MULTIMODAL EVALUATION OF FOVEAL SPARING IN PATIENTS WITH GEOGRAPHICATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION. Retina. 33(3). 482–489. 31 indexed citations
17.
Querques, Giuseppe, D. Kühn, Nathalie Massamba, et al.. (2011). Perifoveal exudative vascular anomalous complex. Journal Français d Ophtalmologie. 34(8). 559.e1–559.e4. 47 indexed citations
18.
Leveziel, Nicolas, Cécile Delcourt, Isabelle Carrière, et al.. (2006). NAT–2. Report #1: High HDL and Low PUFAs Levels in Exudative AMD Patients. Investigative Ophthalmology & Visual Science. 47(13). 2181–2181. 1 indexed citations
19.
Leveziel, Nicolas, et al.. (2005). Maculopathie ischémique drépanocytaire résolutive après échange érythrocytaire. Journal Français d Ophtalmologie. 28(6). 642–645. 6 indexed citations
20.
Leveziel, Nicolas, Eric Souied, Nathanaël Benhamou, G. Coscas, & G. Soubrane. (2003). OCT Features in Vitelliform Macular Dystrophy (Best's Disease). Investigative Ophthalmology & Visual Science. 44(13). 5102–5102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026